Back to search
FDAFDA · Food and drugs·Recall number D-0657-2025

Entecavir Tablets, USP, 1 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.

Published September 24, 2025 · Recall initiated: September 4, 2025

Summary

FDA records drug Class II recall D-0657-2025, published September 24, 2025 and initiated September 4, 2025. Recalling firm: Zydus Pharmaceuticals (USA) Inc; Status: Ongoing; Reported quantity: 4440 bottles; Lot: Lot E309377, Exp 11/30/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurity/Degradation Specifications

What to do

Voluntary: Firm initiated

Get an email if ENTECAVIR has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ENTECAVIR
Manufacturer
Zydus Pharmaceuticals (USA) Inc
Distributor
U.S. Nationwide
Lot
Lot E309377, Exp 11/30/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Entecavir Tablets, USP, 1 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06. recalled?

Yes. FDA published recall D-0657-2025 on September 24, 2025. Reported hazard: Failed Impurity/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ENTECAVIR.